Clinical chemistry autoimmune IVDs - ARTG 440690
Access comprehensive regulatory information for Clinical chemistry autoimmune IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 440690 and sponsored by Bio-Strategy Pty Ltd, manufactured by AliveDx Suisse SA in Switzerland. The device registration started on February 12, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The MosaiQ AIplex CTD is composed of single use immunoassay microarrays to be used in conjunction with the automated MosaiQ 125 instrument and the associated MosaiQ reagents. It is intended for the in vitro simultaneous qualitative detection of antibodies directed to native dsDNA and to Extractable Nuclear Antigens (ENAs: TRIM21 (SS-A52), SS-A 60, SS-B, Sm, Sm/RNP, U1RNP, Scl-70, Jo-1, CENP B, Ribosomal P Protein) in human serum